Article | population | intervention | groups | Outcomes measured | Timing | Study design |
Mijwel, Backman, Bolam 2018 Breast Cancer Research and Treatment | 260 women with stage I-III breast cancer 18 - 17 years undergoing chemotherapy for curative intent | Aerobic training, HIIT, resistance training 2x/week for 16 weeks | AT-HIIT, RT-HIIT | Cardiorespiratory function, muscle strength, body mass, pressure pain threshold | Undergoing chemotherapy | Randomized controlled trial |
Omar M, Gwada, Omar G 2019 Journal of Cancer Education | 60 women ages 18+ years with breast cancer related lymphedema symptoms | Low-intensity resistance exercises and compression garment 3x/week for 8 weeks | Low-intensity resistance training alone, Low-intensity resistance training with resistance garment | lymphedema volume determined by percentage reduction of excess limb volume | N/A | Randomized controlled trial |
Fugazzaro, Costi, Manini, 2017, BMC Cancer | 40 patients with stage I-II NSCLC | Aerobic and resistance training 2 − 3x/week for 6 months | Intervention group participated in aerobic and resistance training | Long-term exercise capacity measured by 6-min walk test, pain relief | Begins before surgery; results measured at 1 month and 6 months post-surgery | Randomized controlled trial |
Brocki, Andreasen, Nielsen, 2013, Lung Cancer | 78 early-stage lung cancer patients | Aerobic exercises, resistance training, dyspnea management 1 hr/week for 10 weeks | Intervention group participated in aerobic and resistance training | HRQoL (survey), 6-min walk test, lung function (spirometry) | Treatments imposed 3 weeks to 4 months after surgery. Results measured immediately after surgery, and at 4 & 12 months. Thoracotomy was performed in 77% of participants | Randomized controlled trial |
Nilsen, Raastad, Skovlund 2015 Acta Oncologica | 58 males with prostate ca undergoing ADT | High-load strength training 3x/week for 16 weeks | Intervention group participated in heavy resistance training | Lean body mass, bone density (DXA), physical strength (1RM), HRQoL (questionnaire) | Undergoing ADT | Randomized controlled trial |